SVRA - SNDL ZOM among premarket gainers

Can-Fite BioPharma Ltd. (CANF) +87% on out-licensing psoriasis, liver disease drug rights.SunLink Health Systems, Inc. (SSY) +55% on announcing $2 Million expansion, capital and operating improvements at Trace Regional Hospital.Annovis Bio, Inc. (ANVS) +37% as ANVS401 improves speed, coordination in Parkinson's patients.Anchiano Therapeutics Ltd. (ANCN) +28% on Chemomab merger approval.Enzo Biochem, Inc. (ENZ) +29% on Q2 results.Savara Inc. (SVRA) +27% on expected to receive FDA nod for Alzheimer’s therapy and Solid Bioscience upgraded in today’s analyst action.Streamline Health Solutions, Inc. (STRM) +28%. on new contract for streamline health eValuator.iSun, Inc. (ISUN) +23% on Q4 results.Sypris Solutions, Inc. (SYPR) +24%.NTN Buzztime, Inc. (NTN) +22% on merger approval with Brooklyn ImmunoTherapeutics.Zedge, Inc. (ZDGE) +17% on Q2 results.iCAD, Inc. (ICAD) +16% on FDA clearance of Profound AI 3.0 in 3D mammography.KemPharm, Inc. (KMPH) +17%.Fintech Acquisition Corp. V (FTCVU) +15% on report of deal for trading platform eToro.AzurRx BioPharma, Inc. (AZRX) +15% on enrollment completion in study of MS1819 in cystic fibrosis.Xunlei Limited (XNET) +14% on Q4

For further details see:

SNDL, ZOM among premarket gainers